Loading stock data…
$4.04-0.06 (-1.46%)
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States.
Treace Medical Concepts, Inc. in the Healthcare sector is trading at $4.04 with a market capitalization of $315M. Wall Street consensus targets $5.50 (3 analysts), implying a +36.1% move over the next 12 months. The stock is currently 43% below its 52-week high of $7.08, remaining 28.7% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $45.38M↓ | $47.20M↓ | $62.52M↑ | $50.21M↑ | $47.39M |
| Gross Profit | $35.61M↓ | $37.41M↓ | $50.40M↑ | $39.71M↑ | $37.75M |
| Operating Income | -$14.96M↑ | -$17.17M↓ | -$5.92M↑ | -$15.68M↑ | -$16.97M |
| Net Income | -$15.87M↑ | -$17.96M↓ | -$9.39M↑ | -$16.29M↑ | -$17.40M |
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stab...